Photobiomodulation context
Research on photobiomodulation (PBM), also known as light therapy, shows that light can influence biological processes in the body. PBM typically uses lasers, LEDs, or other light sources within the visible and near-infrared spectrum, and has been studied in areas such as pain, inflammation, wound healing, recovery, and tissue response.
Much of the established PBM research explains these effects through the interaction between light and the body’s own light-sensitive cellular structures. In classical PBM, mechanisms often discussed include mitochondria, cytochrome c oxidase, ATP, reactive oxygen species (ROS), and intracellular signaling.
Gunalight belongs within this broader field of light biology, but it was not developed as a traditional PBM, laser, or red-light therapy device. Gunalight is a patented technology in which light passes through a spherical quartz crystal, creating a measured physical signature that differs from conventional light therapy.
This is also why we believe Gunalight should be considered a technology category of its own. An independent ATP/ROS screening did not show a classical ATP/ROS pattern under the tested conditions. This means that Gunalight cannot easily be explained as conventional photobiomodulation, where effects are often linked to increased ATP or a typical ROS response.
For us, this is an important finding. It supports the need to continue exploring Gunalight based on its own physical signature, practical user response, and possible biophysical mechanisms — rather than only through established models for conventional light therapy.
Therefore, PBM research is presented here as relevant background: it shows that light can have biological significance. Gunalight goes one step further by combining light, frequency, and material technology in a patented invention with a unique measured energy profile.
